Volunteers sought for second homegrown COVID-19 vaccine trials
People, aged from 18-59 and residing in Hanoi, can register for human trials of Vietnam’s second COVID-19 vaccine candidate COVIVAC from March 5 morning.
People, aged from 18-59 and residing in Hanoi, are encouraged to register for human trials of Vietnam’s second COVID-19 vaccine candidate COVIVAC (Photo: VNA)
Hanoi (VNA) – People, aged from 18-59 and residing in Hanoi, canregister for human trials of Vietnam’s second COVID-19 vaccine candidateCOVIVAC from March 5 morning.
In the first phase of the trials, 150 healthy volunteerswill be injected with two doses of 0.5ml with an interval of 28 days.
They will be divided into five groups, including one groupprovided with placebo shots, and their health will be closely monitored within24 hours after injections.
Each volunteer will have their health checked-up eight timesin 12 months.
After 43 days since the first phase starts and shows goodresults, the second phase will be carried out at the medical centre of ThaiBinh province’s Vu Thu district, with 300 volunteers.
The homegrown vaccine has been developed by the NhaTrang-based Institute of Vaccines and Medical Biologicals (IVAC) and the HanoiMedical University since last May, using primary chicken embryo cell culture, atechnique the institute used previously to successfully produce seasonal fluvaccines.
COVIVAC has undergone pre-clinical trials in India, the US,and Vietnam, said IVAC Director Dr. Duong Huu Thai, adding that results showedthat it satisfies all conditions to be tested on humans.
The vaccine candidate demonstrated high immunogenicityduring pre-clinical trials. It was created based on studies of new SARS-CoV-2strains.
This vaccine is expected to have a price of around 60,000VND (2.59 USD) per dose./.
The first 35 volunteers received injections of the locally-produced Nano Covax vaccine in the 2nd phase of human trials at the Military Medical University in Hanoi on February 26. Nanocovax is Vietnam’s first COVID-19 vaccine to reach the human trial stage.
The Ministry of Health (MoH) on February 27 received 20 billion VND (866,620 USD) from conglomerate Vingroup for the clinical trials of homegrown COVID-19 vaccine COVIVAC.
Deputy Minister of Health Truong Quoc Cuong has said COVID-19 vaccination will begin right after the Ministry of Health receives an accreditation certificate from the Republic of Korea (RoK), scheduled for late this week or early next week.
Prime Minister Nguyen Xuan Phuc on March 2 asked the Ministry of Health to conduct widespread COVID-19 vaccination this week after the first 117,600 doses arrived in Vietnam on February 24.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
People, aged from 18-59 and residing in Hanoi, are encouraged to register for human trials of Vietnam’s second COVID-19 vaccine candidate COVIVAC (Photo: VNA) 
